Thelansis

  Hypoglycemia stands as the prevailing metabolic aberration observed in neonatal populations. The precise definition, clinical implications, and optimal management strategies for neonatal hypoglycemia remain subjects of ongoing debate. However, transient cases predominate, exhibiting prompt responsiveness to therapeutic interventions and generally portend an auspicious prognosis. Conversely, sustained hypoglycemic states are more inclined to accompany aberrant endocrine profiles, notably hyperinsulinemia, and potentially elicit neurological complications over the long term. Seizures represent a prominent manifestation of hypoglycemia, bearing the potential for consequential neuromorbidity. Among hypoglycemic conditions, insulin-induced hypoglycemia in diabetic individuals emerges as the most prevalent. Although insulinoma is a rare occurrence, it ranks as the most frequently encountered hormone-secreting islet cell tumor. Its diagnosis hinges upon the concurrence of hypoglycemia...